DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

B of A Securities Maintains Buy on Fulcrum Therapeutics, Raises Price Target to $22

B of A Securities maintains Fulcrum Therapeutics (NASDAQ:FULC) with a Buy and raises the price target from $19 to $22.

Benzinga · 01/23/2020 18:15

B of A Securities maintains Fulcrum Therapeutics (NASDAQ:FULC) with a Buy and raises the price target from $19 to $22.